Burkitt, ALL, B-ALL, T-ALL Flashcards
Burkitt Lymphoma Morphology:
-Wright stained blood or Cytologic Preps
Deep blue cytoplasm w/
-Lipid vacuoles
B-ALL clinical presentation.
MC malignancy of Children
-Peaks at 3 years of age
T-ALL Molecular abnormality.
TCR rearrangement in nearly ALL cases
-IgH rearrangement in 10-20%
Lymphoblastic Leukemia (ALL) Vs Lymphoblastic Lymphoma (LBL): -Lesions involving tissue and sparing blood and BM.
LBL
General characteristics of African (endemic) BL.
- Location
- Age
- EBV association
- Jaw mass
- Kids
- EBV Positive
T-LBL vs. Thymoma is best distinguished by what?
Epithelial Markers
-EMA
B-ALL/LBL favorable prognosis findings:
- WBC count
- Ages
- M/F
- Chemo response
- Chromosome number
B-ALL/LBL favorable prognosis findings:
- Low initial WBC count
- Ages 2-10 y/o
- Females
- Complete remission (d14 BM)
- Hyperdiploidy is favorable (higher chromosome number)
B-ALL/LBL IHC:
-Negative for (2)
- CD20
- sIg
B-ALL/LBL with recurrent genetic abnormalities:
- Most common structural abnormality
- Good or Poor prognosis
t(9;22) BCR/ABL1
- minor breakpoint (m-bcr) rearrangement
- chimeric protein of 190kD
Poor prognosis
B-ALL/LBL molecular/cytogenetic findings.
6q, 9p, 12p abnormalities
B-ALL/LBL IHC:
-Positive for (7)
- CD10
- CD19
- CD34
- CD99
- PAX-5
- TdT (nuclear)
- HLA-DR
T/F: PCNA (Ki67) is positive in >99% of cells in BL.
True
Burkitt Lymphoma IHC:
-Negative for (5)
- CD5
- CD23
- CD34
- Tdt
- bcl-2
T-ALL IHC:
- Positive for (7)
- Variable (1)
- Negative (1)
Positive for:
- CD2
- CD3 (cytoplasmic)
- CD5
- CD7
- CD99
- TdT (nuclear)
- CD13/CD33 in some cases (myeloid markers)
Variable for: CD34
Negative for: HLA-DR
Burkitt Lymphoma IHC:
-Positive for (7)
- CD10
- CD19
- CD20
- CD22
- bcl-6
- C-myc
- Surface Ig (sIg)